[Determination of the necessary time for prevention of thromboembolism using heparin/dihydroergotamine during implantation of partial hip joint endoprostheses].
The paper presents investigation of efficiency of thromboembolic prophylaxis heparin/dihydroergotamine in patients with femur cervix fracture undergoing standard operational treatment with insertion of partial femur endoprosthesis. Various thrombo-prophylaxis durations have been considered, after the patients have been divided into a control group (without thrombo-prophylaxis) and the group of patients which were subjected to thrombo-prophylaxis for period of up to one week and two, three and four weeks. The investigations have encompassed a rather large group of 162 patients operatively treated within a 12 year period (1974-85) at Orthopaedic Clinic in Biograd o/s. Based on the analysis of general characteristics of standard cases, where thrombo-prophylaxis duration has been examined by statistical methods applied to observed material, and on the basis of comparison with previously published experiences, optimum duration of thromboembolic prophylaxis is proposed.
Maldini
B
B
Matijasević
B
B
D000368:Aged; D004087:Dihydroergotamine / Q000008:administration & dosage* / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006493:Heparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors
D004338:Drug Combinations; D004087:Dihydroergotamine; D006493:Heparin
Odredjivanje potrebnog trajanja trombo-embolicke profilakse heparin/dihidroergotamin pri ugradnji parcijalne endoproteze kuka.